Antoine Papiernik

You need to leverage.

So we need to be coherent.

If we think that digital medicine is super important, we need to also apply it to ourselves.

We need to be able to say, well, we're going to change the way.

We've been there for 50 years, but if you're sitting on your lawn

morals, we're going to be taken over by others.

So that's super important in how we operate.

No, it has.

We haven't gone to the full circle, meaning invested in that company that we said no because of our relooking at data.

But it will happen eventually.

I can bet that it will happen.

And the reason it will, because as I said, this system that we're using, Sophia, is connected to Affinity, to every deal that we've ever registered in Affinity.

I think we have 30 something, 35,000 deals that we've seen.

So any link to this.

So if you're a newbie, you're coming in, you have a great idea, you just find a patent, it needs to be published for us to see it, about this new system,

mechanism, well, Sophia will help us decipher any paper, any clinical trial, any key opinion leaders in the back end of nowhere that is the expert in this.

I was visiting an LP of ours, and I will tell you that this system is great.

I think one of the reasons we've managed to raise $1.5 billion in the last 12 months is also because people think, okay, they're living with their time, and they are

Whether you can today say that we are generating larger returns, thanks to that, I don't think we can say this, but we are living with our time.

And I was visiting a German LP of ours, and real time, and I asked him, where are you from in Germany?